CRP and neoplasm: Taken all together, the CRP enhancement of anti-tumorigenic lysis by PBMC and the potential for micrometastases to have favorable ligand exposure environments for CRP action, it is possible that increases in CRP in micrometastasis sites could contribute to the development of the anti-tumor memory T cell response through exposure of new Ags.